EL7.AI
StocksMedium•28 October 2026•
5 min read

MicroVision Reports $0.45 Per-Share Loss and $2.4 Million in Third-Quarter Revenue

Key Facts

1Net loss was $12.2 million, or $0.45 per share, in the third quarter of 2026, compared with $14.2 million and $0.72 per share a year earlier.
2Revenue was $2.4 million, versus expectations of $2.5 million, up from $0.2 million in the third quarter of 2025.
3Cash and cash equivalents totaled $28.9 million on September 30, 2026, and the company used $13.6 million in cash in operations during the quarter.
4The company maintained its 2026 revenue outlook at $10 million to $15 million and said 2027 revenue would be at least twice the level expected for 2026.

MicroVision reported on October 28 a net loss of $12.2 million, or $0.45 per share, in the third quarter of 2026, compared with expectations for a loss of $0.75 per share. Revenue was $2.4 million, below analysts’ estimate of $2.5 million, according to Reuters coverage via Investing.com. The loss per share was therefore smaller than expected, but the company remained loss-making, while revenue fell short of market estimates. At the same time, the results showed higher sales than a year earlier and an improvement in gross margin. The company said demand for IRIS sensors grew strongly in the second half of the year and that it had begun fulfilling its backlog of purchase orders.

Quarterly revenue rose to $2.4 million from $0.2 million in the same period of 2025, according to the investor relations statement. For the first nine months, revenue was $4.8 million, nearly five times the $1.0 million recorded in the corresponding period last year. Gross margin was 50% in the third quarter, compared with a negative margin a year earlier. Year-to-date gross margin also rose to 46%, compared with a negative margin of 126% in the first nine months of 2025. The improvement in sales and margin points to an expansion in commercial activity, but came alongside continued net losses.

Net loss narrowed to $12.2 million in the third quarter from $14.2 million a year earlier, and loss per share fell to $0.45 from $0.72, the company said. Adjusted EBITDA loss was $11.1 million, compared with $11.7 million in the third quarter of 2025. But operating expenses rose to $22.5 million from $12.0 million a year earlier, which the company attributed to its acquisition of Luminar. Operating expenses were about 7.5% below their average quarterly level in the first half of 2026, which was $24.4 million. MicroVision said the quarter’s results included a $6.3 million cash research and development grant from the German government.

Cash and cash equivalents totaled $28.9 million on September 30, 2026, while the company used $13.6 million in operating cash during the quarter, according to its statement. In its second-quarter report, MicroVision had estimated cash burn of about $60 million for 2026, with cash use expected to return to more typical levels in the second half after non-recurring expenses in the first half. In an update issued on October 7, it said it was aligning operating expenses and capital allocation with commercial opportunities, and expected savings and a meaningful reduction in cash burn in 2027 compared with 2026. In its third-quarter results, the company estimated 2027 operating cash burn at about $40 million and said that was about one-third below current levels. These figures reflect the continued reliance of its growth plans on liquidity management alongside increased shipments and revenue.

Management said it had customer purchase orders worth nearly $10 million awaiting shipment, and that most of the inventory tied to them had already been built. It expected shipments from existing orders, wider IRIS sales, growth in MOVIA product sales and the Blue-Band alliance to support revenue growth in 2027. The company announced on October 22 that commercial production of MOVIA Pro had begun to meet customer demand, before reporting its third-quarter results. In its results statement, it also said it was currently delivering products against its purchase-order backlog, following growth in demand for IRIS sensors and the launch of MOVIA Pro production. This puts shipment execution at the center of the growth path outlined by management, alongside expanding sales of existing products.

MicroVision maintained its 2026 revenue outlook at a range of $10 million to $15 million, and said 2027 revenue was expected to be at least twice the level anticipated in 2026. The company had reaffirmed this range in a business update issued on October 7, when it also forecast that revenue would double in 2027. In the second quarter, it recorded revenue of $1.5 million, compared with $0.2 million in the second quarter of 2025, attributing the increase to higher sensor shipments and development revenue. Its second-quarter report also said it had completed a 1-to-15 reverse stock split, effective August 1, 2026. The investor relations page showed no upcoming events listed at the time of review, while the third-quarter results call held on October 28 appeared among past events.

MicroVision shares closed the regular session at $1.30 on October 28, up 4.84% from the previous session’s close of $1.24, according to Reuters via Investing.com. The stock was recorded at $1.299 after the close. The share move came on the day the company announced results combining a smaller loss than analysts expected with revenue slightly below estimates. The report also showed a significant year-over-year increase in revenue and an improvement in gross margin, alongside continuing losses and operating cash use. The company did not list a date for a subsequent event on its investor relations events page after the results call.